Private Sector Partnership Addressing Emerging Zoonoses and Antimicrobial Resistance | GH BAA 2018 ADDENDUM02

Opportunity Information: Apply for GH BAA 2018 ADDENDUM02

The "Private Sector Partnership Addressing Emerging Zoonoses and Antimicrobial Resistance" opportunity (Funding Opportunity Number: GH BAA 2018 ADDENDUM02) is a U.S. Agency for International Development (USAID) discretionary funding announcement in the health area (CFDA 98.001). It is designed to catalyze research and development solutions that are not only technically strong, but also market-driven and built to last without permanent donor support. The core idea is to harness private sector capabilities, incentives, and speed to complement public sector mandates and reach, especially in areas where governments cannot effectively act alone.

At the center of the challenge is the link between animal health, human health, and food systems. Applicants are expected to propose innovations that simultaneously move the needle on two big global goals: expanding access to safe, affordable, high-quality animal-source foods (such as meat, eggs, dairy, and fish) and strengthening global health security by reducing the risks posed by emerging zoonoses (diseases that spill over from animals to humans), trans-boundary animal diseases (diseases that spread across borders and disrupt trade and livelihoods), and antimicrobial resistance (AMR). In practice, this means proposals should treat livestock and animal-source food value chains as both an economic engine and a potential pathway for disease emergence, then offer solutions that increase productivity and nutrition while reducing health threats.

A defining feature of this opportunity is its emphasis on public-private collaboration as the main mechanism for change. Proposed solutions should sit at the intersection of government priorities and private sector execution, showing clearly how partners will work together in a way that creates additional value. USAID is looking for approaches that either build on existing tools and systems in a meaningful way or introduce new approaches that go beyond what public institutions can realistically develop, fund, scale, or sustain on their own. That generally implies leveraging private sector assets like distribution networks, manufacturing capacity, data systems, financing, product development pipelines, or service delivery models, while aligning with public sector needs such as surveillance, standards, regulatory enforcement, and equitable access.

The announcement also signals that solutions should be designed with real-world variation in mind. Because disease risks, agricultural practices, regulatory environments, and market readiness differ significantly by region, strong concepts are expected to account for differences in policy, capacity, and local incentives. At the same time, USAID is explicitly interested in approaches that have the potential to be widely applicable and scalable, rather than one-off pilots that only work in a narrow context. In other words, adaptability to local conditions should be built in, but the underlying model should be capable of expansion across geographies.

Operationally, the opportunity is open to unrestricted eligible applicants, indicating a broad pool of potential submitters that can include private companies, consortia, nonprofit organizations, and other entities that can credibly lead or participate in market-based R&D partnerships. The award ceiling is listed at up to $40,000,000, suggesting support for large, multi-partner efforts with meaningful scale or ambition. The original closing date is June 24, 2019, and the opportunity record shows a creation date of May 15, 2019, placing it within a timeframe when global health security and One Health approaches were increasingly being tied to food systems, agricultural development, and private sector engagement.

Overall, this grant opportunity is aimed at generating sustainable innovations at the One Health nexus, where improvements in animal-source food production and safety can be pursued in tandem with better prevention and control of zoonotic threats, cross-border animal disease spread, and antimicrobial resistance. The strongest proposals under this kind of challenge are typically those that can demonstrate a viable market pathway, clear incentives for private sector participation, credible collaboration with public authorities, and a strategy for scaling solutions beyond a single project footprint while still fitting local realities.

• The Agency for International Development in the health sector is offering a public funding opportunity titled "Private Sector Partnership Addressing Emerging Zoonoses and Antimicrobial Resistance" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001.
• This funding opportunity was created on 2019-05-15.
• Applicants must submit their applications by 2019-06-24. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $40,000,000.00 in funding.
• Eligible applicants include: Unrestricted.

Apply for GH BAA 2018 ADDENDUM02

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: